drugset / Trial / NCT02004626

Evaluate the Noninferiority of Medicines Treating Uninfected Pressure Ulcers.

NCT02004626

RandomizedParallel-groupDouble-blindTreatment

Summary

This is a Clinical study Phase III, Prospective, Randomized, Controlled, Double-blind, Multicenter, National, Non-inferiority. Its purpose is to determine the noninferiority in efficacy of an investigational product in relation to the product available in the market intended of treating pressure ulcers.

Timeline

Start
2015-01
Primary completion
2015-06
Completion
2015-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Collagenase Clostridium Histolyticum Protein / enzyme biologic 0.6 iu Topical

Indications